Izotropic Corporation

Commercializing a Dedicated Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of Breast Cancers

Recent News

  • FDA Consultant Joins Izotropic Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - May 20, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that Anita Nosratieh Ph.D., as a new member of the Company's Advisory Board. Nosratieh began her career as a lead reviewer at the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) where she worked with companies seeking approval of breast cancer screening and diagnostic devices. As lead reviewer, she...

    2020-05-20 3:01 AM ET
  • Izotropic Engages StarFish Medical for Design and Development of Commercial Breast CT Model

    Vancouver, British Columbia--(Newsfile Corp. - May 13, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has engaged StarFish Medical, Canada's largest medical device design, development and contract manufacturing company, to complete the final design and development of the Company's commercial breast CT model. StarFish Medical Founder and CEO Scott Phillips commented on the collaboration: "We have worked with numerous companies in the medical and breast imaging spaces. Izotropic...

    2020-05-13 3:01 AM ET
  • Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy

    Vancouver, British Columbia--(Newsfile Corp. - May 7, 2020) -  Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the United States Patent and Trademark Office has issued U. S. Patent No. 11/913494, entitled "Biopsy Systems For Breast Computed Tomography". A Notice of Allowance was announced for this patent in February of this year. The patent covers the use of Izotropic Corporation's dedicated Breast CT Imaging System for robotic guided biopsy (Izotropic...

    2020-05-07 3:00 AM ET
  • Izotropic Announces Addition of George Burkett, M.Eng., to Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - April 22, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the addition of Mr. George Burkett, M.Eng., to the Advisory Board. Mr. Burkett graduated with a Master's Degree in Mechanical and Aeronautical Engineering in 2002 and has spent the last 15 years working at UC Davis Medical Center in Sacramento, CA (UC Davis). He is the primary engineer responsible for developing Breast Computed Tomography...

    2020-04-22 9:00 AM ET
  • Izotropic Announces Issuance of Patent to Measure Breast Density with Breast CT Technology

    Vancouver, British Columbia--(Newsfile Corp. - April 15, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") Izotropic Corporation is pleased to announce the United States Patent and Trademark Office has issued U. S. Patent No. 10,548,549, entitled "Measuring Breast Density Using Breast Computed Tomography" for a 20-year term, expiring in 2037. This patent covers the use of the Company's Breast CT Imaging System to measure breast density. Principal Founder and Director Dr. John Boone...

    2020-04-15 9:00 AM ET
  • Izotropic Provides Update on Globally Licensed Breast CT Technology

    Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to provide an update regarding early stage commercialization action plans to bring its globally licensed breast CT technology to market.The first initiative underway includes collaborative design and engineering of the commercial model and preparation for manufacturing and submission for FDA approval and European CE Mark. The second is a near-term initiative that includes proposals and presentations to...

    2020-02-27 8:30 AM ET
  • Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027

    Vancouver, British Columbia--(Newsfile Corp. - February 26, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") The Company is pleased to announce that it has extended the terms of its exclusive global License Agreement with The Regents of the University of California. The amendments under the revised exclusive global License Agreement relate to the formal Commercialization Plan of breast CT technology developed at UC Davis Medical Center in Sacramento, CA. Due to unforeseen delays...

    2020-02-26 8:30 AM ET
  • Izotropic Receives Notice of Allowance for Measuring Breast Density from US Patent Office

    Vancouver, British Columbia--(Newsfile Corp. - February 19, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") Izotropic Corporation is pleased to announce that a notice of allowance has been received from the United States Patent and Trademark office ("USPTO") for the patent application No. 15/669829, entitled "Measuring Breast Density Using Breast Computed Tomography." This notice of allowance is the final step before the patent is formally issued. This patent covers the use of Izotropic...

    2020-02-19 8:30 AM ET